Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Brandle: Cost effectiveness of statin therapy for the primary prevention of major coronary.... (0.12 sec) 

Cost effectiveness of statin therapy for the primary prevention of major coronary …


M Brandle, MB Davidson, DL Schriger, B Lorber, … - Diabetes Care, 2003 - Am Diabetes Assoc
RESULTS—There are ∼8.2 million Americans with diabetes, LDL cholesterol levels ≥100
mg/dl, and no clinical evidence of cardiovascular disease. Each year, statin therapy could prevent
∼71,000 major coronary events in this population. In the subgroup with LDL cholesterol ...
Cited by 40 - Related articles - BL Direct - All 6 versions

How cost-effective is the treatment of dyslipidemia in patients with diabetes but …


SA Grover, L Coupal, H Zowall, CM Alexander, TW … - Diabetes Care, 2001 - Am Diabetes Assoc
OBJECTIVE— Epidemiological studies have shown that the risk of myocardial infarction (MI)
in diabetic patients without cardiovascular disease (CVD) is comparable to the risk of MI in patients
with CVD. We used a validated Markov model to compare the long-term costs and ...
Cited by 76 - Related articles - BL Direct - All 12 versions

Cost-effectiveness of primary prevention of cardiovascular disease with …


M Raikou, A McGuire, HM Colhoun, DJ Betteridge, PN … - Diabetologia, 2007 - Springer
Page 1. ARTICLE Cost-effectiveness of primary prevention of cardiovascular disease with
atorvastatin in type 2 diabetes: results from the Collaborative Atorvastatin Diabetes Study (CARDS)
M. Raikou & A. McGuire & HM Colhoun & DJ Betteridge & PN Durrington & GA Hitman & ...
Cited by 5 - Related articles - BL Direct - All 7 versions

Review: PROactive 03: Pioglitazone, type 2 diabetes and reducing macrovascular …

- sherbornegibbs.com [PDF] 
J Bottomley, AJ Palmer, R Williams, J … - The British Journal of …, 2006 - dvd.sagepub.com
Page 1. http://dvd.sagepub.com The British Journal of Diabetes & Vascular Disease
DOI: 10.1177/14746514060060020401 2006; 6; 63 British Journal of Diabetes &
Vascular Disease Julia Bottomley, Andrew J Palmer, Rhys ...
Cited by 6 - Related articles - All 9 versions

Влияние симвастатина и фенофибрата на показатели углеводного и …


НН Жердева, ТЮ Юзвенко, ГВ Бабина, АГ Пхакадзе, … - rql.kiev.ua
В последние годы во всех странах отмечается постоянное возрастание заболеваемости
и распространенности сахарного диабета (СД). В настоящее время в мире насчитывается
более 200 млн пациентов с СД, а в Украине количество зарегистрированных ...
Related articles - Cached

Doba po Heart Protection Study–změníme algoritmus léčby diabetu?


M Kvapil - ČASOPIS PRO POSTGRADUÁLNÍ VZDĚLÁVÁNÍ - tigis.cz
Doba po Heart Protection Study – změníme algoritmus léčby diabetu? Will be Changed the
Algoritm of Diabetes Therapy after Heart Protection Study? Milan Kvapil. Interní klinika FN Motol
a 2. LF UK Praha, přednosta doc. MUDr. Milan Kvapil, CSc. Souhrn. ...
Related articles - Cached - All 4 versions

Statin Treatment in Diabetic Subjects: What the Heart Protection Study Shows

- wesrch.com [PDF] 
RB Goldberg - Clinical Diabetes, 2003 - Am Diabetes Assoc
Subjects and Methods. A total of 5,963 adults aged 40–80 years, known to have diabetes, with
and without cardiovascular disease (CVD), and with total and LDL cholesterol levels not considered
by their general practitioners to warrant statin therapy were randomized to simvastatin, 40 ...
Related articles - BL Direct - All 8 versions

[CITATION] Diabetes-a state of premature cardiovascular death


M Fisher, K Shaw - Practical Diabetes International, 2001 - interscience.wiley.com
It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ...
Cited by 6 - Related articles - BL Direct

Rationale for New American Diabetes Association Guidelines: Are National …


S Haffner - The American journal of cardiology, 2005 - Elsevier
Both the American Diabetes Association (ADA) and the National Cholesterol Education Program
(NCEP) consider type 2 diabetes mellitus to be a coronary artery disease (CAD) risk equivalent
and thus suggest that patients with either diabetes or CAD should have their plasma ...
Cited by 8 - Related articles - All 7 versions

CODE-2 UK: Our contribution to a European study of the costs of type 2 diabetes


R Williams, H Baxter, J Bottomley, J Bibby, … - Practical Diabetes …, 2001 - interscience.wiley.com
It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ...
Cited by 11 - Related articles - BL Direct


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google